The Safety of Micro-Implants for the Brain.
brain implant
implant migration
micro-implant
micro-implant GFAP
micro-implant IBA-1
micro-implant safety
microdevice
Journal
Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481
Informations de publication
Date de publication:
2021
2021
Historique:
received:
16
10
2021
accepted:
22
11
2021
entrez:
27
12
2021
pubmed:
28
12
2021
medline:
28
12
2021
Statut:
epublish
Résumé
Technological advancements in electronics and micromachining now allow the development of discrete wireless brain implantable micro-devices. Applications of such devices include stimulation or sensing and could enable direct placement near regions of interest within the brain without the need for electrode leads or separate battery compartments that are at increased risk of breakage and infection. Clinical use of leadless brain implants is accompanied by novel risks, such as migration of the implant. Additionally, the encapsulation material of the implants plays an important role in mitigating unwanted tissue reactions. These risks have the potential to cause harm or reduce the service of life of the implant. In the present study, we have assessed post-implantation tissue reaction and migration of borosilicate glass-encapsulated micro-implants within the cortex of the brain. Twenty borosilicate glass-encapsulated devices (2 × 3.5 × 20 mm) were implanted into the parenchyma of 10 sheep for 6 months. Radiographs were taken directly post-surgery and at 3 and 6 months. Subsequently, sheep were euthanized, and GFAP and IBA-1 histological analysis was performed. The migration of the implants was tracked by reference to two stainless steel screws placed in the skull. We found no significant difference in fluoroscopy intensity of GFAP and a small difference in IBA-1 between implanted tissue and control. There was no glial scar formation found at the site of the implant's track wall. Furthermore, we observed movement of up to 4.6 mm in a subset of implants in the first 3 months of implantation and no movement in any implant during the 3-6-month period of implantation. Subsequent histological analysis revealed no evidence of a migration track or tissue damage. We conclude that the implantation of this discrete micro-implant within the brain does not present additional risk due to migration.
Identifiants
pubmed: 34955740
doi: 10.3389/fnins.2021.796203
pmc: PMC8695845
doi:
Types de publication
Journal Article
Langues
eng
Pagination
796203Informations de copyright
Copyright © 2021 Dabbour, Tan, Kim, Guild, Heppner, McCormick, Wright, Leung, Gallichan, Budgett and Malpas.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
IEEE Trans Biomed Eng. 2008 Apr;55(4):1374-81
pubmed: 18390328
Annu Int Conf IEEE Eng Med Biol Soc. 2017 Jul;2017:234-237
pubmed: 29059853
Neurol Int. 2012 Oct 5;4(3):e18
pubmed: 23355931
Clin Infect Dis. 2011 Apr 15;52(8):1020-3
pubmed: 21460317
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Biol Psychiatry. 2010 Jan 15;67(2):110-6
pubmed: 19914605
Oper Neurosurg (Hagerstown). 2020 Nov 16;19(6):708-714
pubmed: 32710790
JAMA Psychiatry. 2016 May 1;73(5):456-64
pubmed: 27049915
J Neurosci Methods. 2005 Oct 15;148(1):1-18
pubmed: 16198003
Front Neurosci. 2016 Feb 09;10:11
pubmed: 26903786
Ann Neurol. 2000 Sep;48(3):372-6
pubmed: 10976644
Micromachines (Basel). 2018 Sep 06;9(9):
pubmed: 30424376
Magn Reson Imaging. 2007 Nov;25(9):1333-40
pubmed: 17462843
Exp Neurol. 2005 Sep;195(1):115-26
pubmed: 16045910
Biomed Microdevices. 2017 Jun;19(2):32
pubmed: 28425028
J Neurosci Methods. 1991 Oct;39(3):245-51
pubmed: 1787744
J Neurotrauma. 2010 Feb;27(2):317-24
pubmed: 19852586
J Biomed Mater Res A. 2003 Dec 15;67(4):1284-93
pubmed: 14624515
Oper Neurosurg (Hagerstown). 2020 Sep 1;19(3):341-350
pubmed: 31993644
Nat Protoc. 2013 Dec;8(12):2413-2428
pubmed: 24202555
J Neurosurg. 1976 Jan;44(1):80-3
pubmed: 1104779
Biomaterials. 2001 Jan;22(2):175-85
pubmed: 11101161
Epilepsia. 2000 Sep;41(9):1195-200
pubmed: 10999559
Brain. 2010 Sep;133(9):2664-76
pubmed: 20802207
PLoS One. 2009 Dec 09;4(12):e8218
pubmed: 20011034
Front Neurosci. 2020 Jan 10;13:1367
pubmed: 31998057
Brain. 2017 Oct 1;140(10):2722-2736
pubmed: 28969383
N Engl J Med. 2012 Oct 18;367(16):1529-38
pubmed: 23075179
Acta Neurol Scand. 1970;46(1):85-92
pubmed: 4983875
Neurosurgery. 2002 Jun;50(6):1268-74; discussion 1274-6
pubmed: 12015845
Stereotact Funct Neurosurg. 2002;79(3-4):228-33
pubmed: 12890981
Glia. 2002 Nov;40(2):260-9
pubmed: 12379913
Biotechnol Prog. 2000 Sep-Oct;16(5):897-904
pubmed: 11027187
Front Neurosci. 2019 Jul 05;13:689
pubmed: 31333407
World Neurosurg. 2013 Sep-Oct;80(3-4):S27.e17-24
pubmed: 23111230
Neurosurgery. 2008 Feb;62(2):360-6; discussion 366-7
pubmed: 18382313
Lancet Neurol. 2019 Dec;18(12):1112-1122
pubmed: 31587955
Science. 2013 Apr 12;340(6129):211-6
pubmed: 23580530
J Surg Case Rep. 2021 Apr 19;2021(4):rjab105
pubmed: 33927852
Nat Rev Neurol. 2014 May;10(5):261-70
pubmed: 24709892
Lancet Neurol. 2002 Dec;1(8):477-82
pubmed: 12849332
Brain Res. 2003 Sep 5;983(1-2):23-35
pubmed: 12914963
Nat Biomed Eng. 2017 Nov;1(11):862-877
pubmed: 30505625